المؤلفون: Steven Lemery, Patricia Keegan, Richard Pazdur

المصدر: The New England journal of medicine. 377(15)

مصطلحات موضوعية: 0301 basic medicine, Oncology, Adult, Male, medicine.medical_specialty, Programmed Cell Death 1 Receptor, Antineoplastic Agents, Breast Neoplasms, Pembrolizumab, Antibodies, Monoclonal, Humanized, Digestive System Neoplasms, B7-H1 Antigen, 03 medical and health sciences, 0302 clinical medicine, Neoplastic Syndromes, Hereditary, Internal medicine, medicine, Drug approval, Biomarkers, Tumor, Humans, Neoplasm Metastasis, Child, Drug Approval, business.industry, Brain Neoplasms, United States Food and Drug Administration, Fda approval, Cancer, General Medicine, medicine.disease, Tumor site, United States, Surgery, 030104 developmental biology, 030220 oncology & carcinogenesis, Monoclonal, Biomarker (medicine), Female, Microsatellite Instability, Programmed death 1, business, Colorectal Neoplasms, Urogenital Neoplasms

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::68427c62967763e5fc6960ce76a05dbcTest
https://pubmed.ncbi.nlm.nih.gov/29020592Test

المؤلفون: Matthew T. Campbell, Christian Kollmannsberger, Bo Huang, Mariangela Mariani, Jae L. Lee, Balaji Venugopal, John B. A. G. Haanen, Paul B. Robbins, Camilla Fowst, Boris Alekseev, Motohide Uemura, Jing Wang, Alessandra di Pietro, Konstantin Penkov, Robert J. Motzer, Toni K. Choueiri, Michael B. Atkins, Brian I. Rini, Howard Gurney, Aleksander Chudnovsky, James Larkin, Subramanian Hariharan, Wilson H. Miller, Manuela Schmidinger, Aleksandr Vasiliev, Sylvie Negrier, Jens Bedke, Laurence Albiges

المصدر: Translational Cancer Research

مصطلحات موضوعية: Oncology, Adult, Male, medicine.medical_specialty, Axitinib, Programmed Cell Death 1 Receptor, Antineoplastic Agents, 030204 cardiovascular system & hematology, Antibodies, Monoclonal, Humanized, law.invention, Avelumab, 03 medical and health sciences, 0302 clinical medicine, Randomized controlled trial, Renal cell carcinoma, law, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, medicine, Carcinoma, Sunitinib, Humans, Single-Blind Method, 030212 general & internal medicine, Progression-free survival, Carcinoma, Renal Cell, Aged, Aged, 80 and over, business.industry, Antibodies, Monoclonal, General Medicine, Middle Aged, medicine.disease, Kidney Neoplasms, Progression-Free Survival, Clinical trial, Survival Rate, Editorial Commentary, Administration, Intravenous, Female, business, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::17373ecbc5219968a1002917c8de7e81Test
https://pubmed.ncbi.nlm.nih.gov/35117136Test

المؤلفون: Matthew G. Fury, Kosalai Kal Mohan, Jade Homsi, Irene Brana, Anne Lynn S. Chang, Dirk Schadendorf, Jiaxin Niu, Leonel Hernandez-Aya, Jingjin Li, Alexander Guminski, Badri Modi, Israel Lowy, Jocelyn Booth, Victor Moreno, Melissa Lynne Johnson, Elizabeth Stankevich, Christine H. Chung, Kyriakos P. Papadopoulos, Hani M. Babiker, Michael R. Migden, Brett G.M. Hughes, Lara Dunn, Danny Rischin, Taofeek K. Owonikoko, Alesha A. Thai, Melissa Mathias, George D. Yancopoulos, Frank Seebach, Karl D. Lewis, Annette M. Lim, Guilherme Rabinowits, Marta Gil-Martin, Nikhil I. Khushalani, Axel Hauschild, Bo Gao, Chrysalyne D. Schmults, Siyu Li

المصدر: The New England journal of medicine. 379(4)

مصطلحات موضوعية: 0301 basic medicine, Adult, Male, medicine.medical_specialty, Skin Neoplasms, Nausea, medicine.medical_treatment, Programmed Cell Death 1 Receptor, Medizin, Phases of clinical research, Antineoplastic Agents, Antibodies, Monoclonal, Humanized, Gastroenterology, Disease-Free Survival, 03 medical and health sciences, 0302 clinical medicine, Internal medicine, medicine, Carcinoma, Humans, Adverse effect, Aged, Neoplasm Staging, Aged, 80 and over, Dose-Response Relationship, Drug, business.industry, Antibodies, Monoclonal, Immunosuppression, General Medicine, Middle Aged, medicine.disease, Rash, Clinical trial, 030104 developmental biology, 030220 oncology & carcinogenesis, Cohort, Carcinoma, Squamous Cell, Female, Immunotherapy, medicine.symptom, business

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1761b684cca8899712eec3d870da07b1Test
https://pubmed.ncbi.nlm.nih.gov/29921845Test